We have previously reported high COX-2 expression in neuroblastoma, a childhood tumor of the sympathetic nervous system, and medulloblastoma, in the central nervous system, and showed a pronounced effect with COX inhibitors in treatment in vivo[3], [5], [18]. This evidence concerns the gene PTGS2 and neuroblastoma.